Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 942 | 2,307 | 1,663 | 2,303 | 5,297 |
| Other current assets | 1 | 17 | 8 | 6 | 19 |
| TOTAL | $1,019 | $2,372 | $1,752 | $2,365 | $5,351 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,019 | $2,372 | $1,752 | $2,365 | $5,351 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 297 | 308 | 212 | 259 | 342 |
| Accrued Expenses | 92 | 132 | 132 | 423 | 52 |
| Other current liabilities | 82 | 1,319 | 2,863 | 6,640 | 5,077 |
| TOTAL | $471 | $1,759 | $3,207 | $7,322 | $5,471 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $471 | $1,759 | $3,207 | $7,322 | $5,471 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,940 | 10,620 | 9,768 | 8,385 | 8,385 |
| Common Shares | 69,401 | 68,656 | 66,790 | 65,952 | 65,952 |
| Retained earnings | -111,533 | -110,874 | -108,698 | -110,543 | -105,380 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $548 | $613 | $-1,455 | $-4,957 | $-120 |
| Total Liabilities And Equity | $1,019 | $2,372 | $1,752 | $2,365 | $5,351 |